News

Glidewell Presents 2024 Guiding Leaders Program

The six-month training initiative elevates women dentists who are looking to become key influencers in the industry.NEWPORT BEACH, CA /…

7 months ago

Nava Health to Open Twelve New Integrative Healthcare Centers in 2024

Nava Health prepares for a big growth leap in 2024 with twelve new centers offering a comprehensive range of services…

7 months ago

Pressure BioSciences, Inc. Reports Q3 2023 Financial Results, Provides Business Update, and Offers Guidance for Remainder of 2023

Investor Call Scheduled for Tuesday, November 21, 2023 at 4:30 p.m. ETSOUTH EASTON, MA / ACCESSWIRE / November 21, 2023…

7 months ago

Hologic to Webcast Presentation at the 6th Annual Evercore ISI HealthCONx Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #holx--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 6th Annual Evercore ISI…

7 months ago

FSD Pharma Inc. Securityholders Approve Plan of Arrangement with Celly Nutrition Corp.

TORONTO, ON / ACCESSWIRE / November 21, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

7 months ago

Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders’ Equity of $44.2M or $3.4/Share

THESSALONIKI, GREECE / ACCESSWIRE / November 21, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

7 months ago

MindBio Therapeutics Team Members Honoured with Industry Leading Awards

VANCOUVER, BC / ACCESSWIRE / November 21, 2023 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to…

7 months ago

Top Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcoming

SAN FRANCISCO, CA / ACCESSWIRE / November 21, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company,…

7 months ago

Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

Data partially fulfills the safety and efficacy hypotheses of one pilot and two Phase II clinical studiesAinos aims to pursue…

7 months ago

Radical Imaging Launches FlexView at RSNA 2023

Radical Imaging's New Viewer-as-a-Service to Be Debuted at the Radiological Society of North America 2023 Annual MeetingBOSTON, MA / ACCESSWIRE…

7 months ago